The MAO-A genotype does not modulate resting brain metabolism in adults.

Medical Department, Brookhaven National Laboratory, Upton, New York 11973, United States.
Psychiatry Research (Impact Factor: 2.68). 09/2008; 164(1):73-6. DOI: 10.1016/j.pscychresns.2007.12.010
Source: PubMed

ABSTRACT Variation in the monoamine-oxidase-A (MAO-A) gene has been associated with volumetric changes in corticolimbic regions with differences in their response to relevant emotional tasks. Here we show no changes in baseline regional brain metabolism as a function of genotype indicating that, unchallenged, corticolimbic activity is not modulated by the MAO-A genotype.


Available from: Ian W Craig, Jun 12, 2015
  • [Show abstract] [Hide abstract]
    ABSTRACT: My response is divided into four sections: (1) is devoted to a potpourri of commentaries that are essentially in agreement with the substance of my target article (with one exception); in (2) I address, in response to one of the commentaries, several issues relating to the use of candidate gene association studies in behavior genetics (in particular those proposing a specific G×E interaction); in (3) I provide a detailed response to several defenses of the twin study methodology; and in (4) I conclude with several reflections on that methodology and the conception of human nature it has fostered.
    Behavioral and Brain Sciences 10/2012; 35(05). DOI:10.1017/S0140525X12001501 · 14.96 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Several new molecular findings and concepts furnish evidence in support of gene-environment interdependence, challenging some of the current tenets and basic statistics of behavioral genetics. I, however, argue that (1) some of the expectations evoked by "neogenomics" are contradicted by findings; and (2) while epigenetic and gene expression effects are complex, they can to some extent be incorporated into "classical" behavioral genetics modeling.
    Behavioral and Brain Sciences 10/2012; 35(5):360. DOI:10.1017/S0140525X12001331 · 14.96 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Brain monoamines, and serotonin in particular, have repeatedly been shown to be linked to different psychiatric conditions such as depression, anxiety, antisocial behaviour, and dependence. Many studies have implicated genetic variability in the genes encoding monoamine oxidase A (MAOA) and the serotonin transporter (5HTT) in modulating susceptibility to these conditions. Paradoxically, the risk variants of these genes have been shown, in vitro, to increase levels of serotonin, although many of the conditions are associated with decreased levels of serotonin. Furthermore, in adult humans, and monkeys with orthologous genetic polymorphisms, there is no observable correlation between these functional genetic variants and the amount or activity of the corresponding proteins in the brain. These seemingly contradictory data might be explained if the association between serotonin and these behavioural and psychiatric conditions were mainly a consequence of events taking place during foetal and neonatal brain development. In this review we explore, based on recent research, the hypothesis that the dual role of serotonin as a neurotransmitter and a neurotrophic factor has a significant impact on behaviour and risk for neuropsychiatric disorders through altered development of limbic neurocircuitry involved in emotional processing, and development of the serotonergic neurons, during early brain development.
    Upsala journal of medical sciences 02/2010; 115(1):2-10. DOI:10.3109/03009730903573246 · 1.71 Impact Factor